Question 2 (27 Marks) Though COVID-19 has affected the majority of companies and individuals worldwide, to some companies; the pandemic is regarded as a window of business opportunity. Simox Pharmaceuticals Cc is one of the few Namibian companies that are locally manufacturing hand sanitizers for use in the fight of COVID-19. The hand sanitizers are produced in masses through a process costing system. The following information was extracted from the company's records for the month ended 31 August 2020: Page 10 of 16 FACULTY OF ECONOMIC & MANAGEMENT SCIENCES Units NS Description Work in process - 1 July 2020 Material 100% complete Conversion 80% 2 000 50 000 45 000 8 000 During the month Units introduced to production Work in process - 31 August 2020 Material 100% Conversion 40% complete Normal loss 500 80 000 60 600 5% of units that reached the inspection point Additional information: Materials are added at the beginning of the process Losses are detected when units are 80% complete. Conversion costs are incurred evenly during the period. 90% of units to account for were completed and transferred out during August 2020. Losses have no scrap value The company uses the FIFO method in valuing its inventory. Required: Prepare the following for the year ended 30 September 2016: Marks 2.1. Physical units schedule 2 2.2 Production schedule clearly showing the equivalent units 6 2.3. Unit cost schedule 5 24. Cost appropriation statement 13 2.5. Between the abnormal loss and normal loss, which one should not be shown as a separate line item in the statement of profit and loss, and 1 why? TOTAL MARKS 27